ATE209887T1 - Verfahren zur verabreichung von förderlichen zusammensetzungen auf die haarfollikel - Google Patents
Verfahren zur verabreichung von förderlichen zusammensetzungen auf die haarfollikelInfo
- Publication number
- ATE209887T1 ATE209887T1 AT94913349T AT94913349T ATE209887T1 AT E209887 T1 ATE209887 T1 AT E209887T1 AT 94913349 T AT94913349 T AT 94913349T AT 94913349 T AT94913349 T AT 94913349T AT E209887 T1 ATE209887 T1 AT E209887T1
- Authority
- AT
- Austria
- Prior art keywords
- hair
- liposomes
- encapsulating
- delivery
- beneficial
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 4
- 230000009286 beneficial effect Effects 0.000 title abstract 3
- 210000003780 hair follicle Anatomy 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 abstract 4
- 150000001875 compounds Chemical class 0.000 abstract 4
- 239000002502 liposome Substances 0.000 abstract 4
- 239000000118 hair dye Substances 0.000 abstract 2
- 102000039446 nucleic acids Human genes 0.000 abstract 2
- 108020004707 nucleic acids Proteins 0.000 abstract 2
- 150000007523 nucleic acids Chemical class 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 201000004384 Alopecia Diseases 0.000 abstract 1
- 102000003425 Tyrosinase Human genes 0.000 abstract 1
- 108060008724 Tyrosinase Proteins 0.000 abstract 1
- 231100000360 alopecia Toxicity 0.000 abstract 1
- 238000001415 gene therapy Methods 0.000 abstract 1
- 210000000442 hair follicle cell Anatomy 0.000 abstract 1
- 230000003779 hair growth Effects 0.000 abstract 1
- 230000003752 improving hair Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y110/00—Oxidoreductases acting on diphenols and related substances as donors (1.10)
- C12Y110/03—Oxidoreductases acting on diphenols and related substances as donors (1.10) with an oxygen as acceptor (1.10.3)
- C12Y110/03001—Catechol oxidase (1.10.3.1), i.e. tyrosinase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/14—Liposomes; Vesicles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/606—Nucleosides; Nucleotides; Nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/10—Preparations for permanently dyeing the hair
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0055—Oxidoreductases (1.) acting on diphenols and related substances as donors (1.10)
- C12N9/0057—Oxidoreductases (1.) acting on diphenols and related substances as donors (1.10) with oxygen as acceptor (1.10.3)
- C12N9/0059—Catechol oxidase (1.10.3.1), i.e. tyrosinase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2468—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1) acting on beta-galactose-glycoside bonds, e.g. carrageenases (3.2.1.83; 3.2.1.157); beta-agarase (3.2.1.81)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y114/00—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14)
- C12Y114/18—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14) with another compound as one donor, and incorporation of one atom of oxygen (1.14.18)
- C12Y114/18001—Tyrosinase (1.14.18.1)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Microbiology (AREA)
- Birds (AREA)
- Biomedical Technology (AREA)
- Nanotechnology (AREA)
- Dermatology (AREA)
- Dispersion Chemistry (AREA)
- Biophysics (AREA)
- Medical Informatics (AREA)
- Crystallography & Structural Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4155393A | 1993-04-02 | 1993-04-02 | |
| US08/181,471 US5641508A (en) | 1994-01-13 | 1994-01-13 | Method for delivering melanin to hair follicles |
| PCT/US1994/003634 WO1994022468A1 (en) | 1993-04-02 | 1994-04-01 | Method for delivering beneficial compositions to hair follicles |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE209887T1 true ATE209887T1 (de) | 2001-12-15 |
Family
ID=26718278
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT94913349T ATE209887T1 (de) | 1993-04-02 | 1994-04-01 | Verfahren zur verabreichung von förderlichen zusammensetzungen auf die haarfollikel |
Country Status (8)
| Country | Link |
|---|---|
| US (5) | US5753263A (de) |
| EP (1) | EP0692972B2 (de) |
| JP (1) | JP2950520B2 (de) |
| AT (1) | ATE209887T1 (de) |
| AU (1) | AU6554594A (de) |
| CA (1) | CA2159626C (de) |
| DE (1) | DE69429337T3 (de) |
| WO (1) | WO1994022468A1 (de) |
Families Citing this family (120)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7556825B2 (en) * | 1993-04-02 | 2009-07-07 | Anticancer, Inc. | Method for promoting hair growth |
| DE69429337T3 (de) * | 1993-04-02 | 2012-08-30 | Anticancer Inc. | Verfahren zur verabreichung von förderlichen zusammensetzungen auf die haarfollikel |
| US6207646B1 (en) * | 1994-07-15 | 2001-03-27 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
| US20030026782A1 (en) * | 1995-02-07 | 2003-02-06 | Arthur M. Krieg | Immunomodulatory oligonucleotides |
| US5480901A (en) * | 1994-10-07 | 1996-01-02 | Zynaxis, Inc. | Method for reducing unwanted cellular adhesions |
| US6844326B2 (en) * | 1995-06-07 | 2005-01-18 | Anticancer, Inc. | Treatment of alopecia |
| US5756122A (en) * | 1995-06-07 | 1998-05-26 | Georgetown University | Liposomally encapsulated nucleic acids having high entrapment efficiencies, method of manufacturer and use thereof for transfection of targeted cells |
| US6261597B1 (en) * | 1995-08-31 | 2001-07-17 | Seymour J. Kurtz | Method for treating periodontal disease |
| US6459805B1 (en) | 1996-03-26 | 2002-10-01 | Childrens Hospital Los Angeles | Fluorescence digital imaging microscopy system |
| US5766214A (en) * | 1996-04-18 | 1998-06-16 | Mehl, Sr.; Thomas L. | Melanin enhanced photothermolysis hair removal |
| JP2000511541A (ja) * | 1996-05-30 | 2000-09-05 | ユニバーシティー オブ ブリティッシュ コロンビア | リポソームアンチセンス送達の効果の増強 |
| US20030125278A1 (en) * | 1997-08-13 | 2003-07-03 | Tang De-Chu C. | Immunization of animals by topical applications of a salmonella-based vector |
| US6706693B1 (en) | 1997-08-13 | 2004-03-16 | The Uab Research Foundation | Vaccination by topical application of genetic vectors |
| US6716823B1 (en) | 1997-08-13 | 2004-04-06 | The Uab Research Foundation | Noninvasive genetic immunization, expression products therefrom, and uses thereof |
| US6348450B1 (en) * | 1997-08-13 | 2002-02-19 | The Uab Research Foundation | Noninvasive genetic immunization, expression products therefrom and uses thereof |
| US20030045492A1 (en) * | 1997-08-13 | 2003-03-06 | Tang De-Chu C. | Vaccination by topical application of recombinant vectors |
| DE69941447D1 (de) * | 1998-01-05 | 2009-11-05 | Univ Washington | Erhöhter transport unter benutzung membranzerstörender stoffe |
| US6348348B1 (en) | 1998-04-07 | 2002-02-19 | The Carnegie Institution Of Washington | Human hairless gene and protein |
| WO1999060167A1 (en) * | 1998-05-21 | 1999-11-25 | Isis Pharmaceuticals, Inc. | Compositions and methods for topical delivery of oligonucleotides |
| US20040247662A1 (en) * | 1998-06-25 | 2004-12-09 | Dow Steven W. | Systemic immune activation method using nucleic acid-lipid complexes |
| US6693086B1 (en) * | 1998-06-25 | 2004-02-17 | National Jewish Medical And Research Center | Systemic immune activation method using nucleic acid-lipid complexes |
| US20030022854A1 (en) | 1998-06-25 | 2003-01-30 | Dow Steven W. | Vaccines using nucleic acid-lipid complexes |
| US6372489B1 (en) | 1998-10-27 | 2002-04-16 | Anticancer, Inc. | Method and model for hair pigmentation |
| EP1127121B1 (de) * | 1998-10-27 | 2005-12-14 | Anticancer, Inc. | Herstellung eines retrovirus, welches den mel-lokus von streptomyces enthält, sowie dessen expression in säugetierzellen |
| FR2791671B1 (fr) | 1999-04-01 | 2001-05-11 | Oreal | Nouveaux composes derives d'esters d'acide benzoique, composition les comprenant et utilisation |
| US20040009936A1 (en) * | 1999-05-03 | 2004-01-15 | Tang De-Chu C. | Vaccine and drug delivery by topical application of vectors and vector extracts |
| GB9918670D0 (en) * | 1999-08-06 | 1999-10-13 | Celltech Therapeutics Ltd | Biological product |
| CA2380640A1 (en) * | 1999-08-18 | 2001-02-22 | Kyowa Hakko Kogyo Co., Ltd. | Hair-growing agent |
| TWI278622B (en) * | 1999-10-29 | 2007-04-11 | Shiseido Co Ltd | Quantitative hair folliculi absorption method and skin absorption measurement method |
| EP1237582B1 (de) * | 1999-12-10 | 2011-09-14 | AntiCancer, Inc. | Verfahren zur einführung von genen in säugetiere |
| US7737108B1 (en) | 2000-01-07 | 2010-06-15 | University Of Washington | Enhanced transport using membrane disruptive agents |
| WO2001051010A1 (en) * | 2000-01-11 | 2001-07-19 | Clinical Results, Inc. | Dermatological suspensions (micro-matrix) |
| JP2004515453A (ja) | 2000-05-05 | 2004-05-27 | ウィスコンシン・アルムナイ・リサーチ・ファウンデーション | 癌を化学療法および放射線療法に付する間に細胞を保護するための組成物および方法 |
| AU2001268594A1 (en) * | 2000-06-22 | 2002-01-02 | Michael F. Holick | Regulation of cellproliferation and differentiation using topically applied peptides |
| US20040022838A1 (en) * | 2001-06-20 | 2004-02-05 | Holick Michael F. | Regulation of cell proliferation and differentiation using topically applied peptides |
| WO2002007674A2 (en) * | 2000-07-21 | 2002-01-31 | Ceramoptec Industries, Inc. | Enhancing compound penetration into hair follicles |
| AU2001296585A1 (en) * | 2000-10-06 | 2002-04-15 | Michael F. Holick | Regulation of cell proliferation and differentiation using topically applied nucleic acid molecules |
| DE10109897A1 (de) * | 2001-02-21 | 2002-11-07 | Novosom Ag | Fakultativ kationische Liposomen und Verwendung dieser |
| US6984395B2 (en) * | 2001-04-11 | 2006-01-10 | Qlt, Inc. | Drug delivery system for hydrophobic drugs |
| WO2002087530A1 (en) * | 2001-04-27 | 2002-11-07 | The General Hospital Corporation | Tyrosinase assay |
| US7923431B2 (en) * | 2001-12-21 | 2011-04-12 | Ferrosan Medical Devices A/S | Haemostatic kit, a method of preparing a haemostatic agent and a method of promoting haemostatis |
| US7858117B2 (en) * | 2002-02-21 | 2010-12-28 | Novosom Ag | Amphoteric liposomes and their use |
| US20030198664A1 (en) * | 2002-03-29 | 2003-10-23 | Sullivan Sean Michael | Lipid mediated screening of drug candidates for identification of active compounds |
| EP1352631A1 (de) * | 2002-04-08 | 2003-10-15 | Kao Corporation | Haarfärbemittel |
| WO2003103616A2 (fr) * | 2002-06-11 | 2003-12-18 | L'oreal | Utilisation d'un agent mimetique de l'activite de la dopachrome tautomerase (trp-2) comme agent protecteur des melanocytes du follicule pileux et applications |
| FR2840531B1 (fr) * | 2002-06-11 | 2004-10-29 | Oreal | Composition cosmetique comprenant un agent mimetique de l'activite de la dopachrome tautomerase (trp-2) pour lutter contre la canitie |
| FR2840530B1 (fr) * | 2002-06-11 | 2004-12-24 | Oreal | Composition cosmetique comprenant un agent inducteur de l'expression de la dopachrome tautomerase (trp-2) pour lutter contre la canitie |
| US7585514B2 (en) * | 2002-06-11 | 2009-09-08 | L'oreal | Administration of agents mimicking DOPAchrome tautomerase (TRP-2) activity for protecting hair follicle melanocytes |
| US7192770B2 (en) * | 2002-09-20 | 2007-03-20 | The General Hospiatal Corporation | Screening for skin wrinkling modulators |
| US7955288B2 (en) * | 2002-12-11 | 2011-06-07 | Ferrosan Medical Devices A/S | Gelatine-based materials as swabs |
| US20060078600A1 (en) * | 2003-02-07 | 2006-04-13 | Lts Lohmann Therapie-Systeme Ag | Transdermal therapeutic system suitable for heat application for promoting the permeation of active substances, and the use thereof |
| FR2850864B1 (fr) * | 2003-02-12 | 2007-04-13 | Oreal | Utilisation d'un inhibiteur de 15-hydroxy prostaglandine deshydrogenase pour favoriser la pigmentation de la peau ou des phaneres |
| EP1594438B1 (de) * | 2003-02-12 | 2013-07-17 | L'Oréal | Verwendung eines 15-Hydroxy-Prostaglandin-Dehydrogenase-Inhibitors zur Förderung der Haut- oder Haar-Pigmentierung |
| US7326717B2 (en) | 2003-05-06 | 2008-02-05 | L'oreal | Pyrimidine n-oxide compounds for stimulating the growth of keratin fibers and/or reducing loss thereof |
| WO2004110350A2 (en) * | 2003-05-14 | 2004-12-23 | Torreypines Therapeutics, Inc. | Compouds and uses thereof in modulating amyloid beta |
| DE10340373A1 (de) * | 2003-08-30 | 2005-03-24 | Henkel Kgaa | Verfahren zur Bestimmung von Haarzyklus-Marken |
| US20050058614A1 (en) * | 2003-09-15 | 2005-03-17 | Allergan, Inc. | Methods for the treatment of gray hair using cyclopentane(ene) heptan(en)oic acid amides |
| AU2004289229B8 (en) * | 2003-11-05 | 2010-10-07 | Osteoscreen, Inc. | Stimulation of hair growth by Ginkgo biloba flavanoids |
| US8535711B2 (en) * | 2004-01-23 | 2013-09-17 | Teikoku Pharma Usa, Inc. | Medication disposal system |
| US7867511B2 (en) | 2004-01-23 | 2011-01-11 | Travanti Pharma Inc. | Abuse potential reduction in abusable substance dosage form |
| CA2554994C (en) * | 2004-01-30 | 2015-05-19 | Ferrosan A/S | Haemostatic sprays and compositions |
| US20050181035A1 (en) * | 2004-02-17 | 2005-08-18 | Dow Steven W. | Systemic immune activation method using non CpG nucleic acids |
| EP1747022A4 (de) * | 2004-04-23 | 2010-03-31 | Univ Columbia | Hemmung von haarloser protein mrna |
| US8168600B2 (en) * | 2004-04-23 | 2012-05-01 | Isis Pharmaceuticals, Inc. | Compositions and methods for topical delivery of oligonucleotides |
| US7706873B2 (en) | 2004-05-05 | 2010-04-27 | Mario Ammirati | System and method for controlled delivery of a therapeutic agent to a target location within an internal body tissue |
| DE102004028465A1 (de) * | 2004-06-11 | 2005-12-29 | Henkel Kgaa | Färbemittel für keratinhaltige Fasern |
| KR20070046093A (ko) * | 2004-07-09 | 2007-05-02 | 훼로산 아크티에 셀스카브 | 히알루론산을 포함하는 지혈 조성물 |
| US20060073117A1 (en) * | 2004-10-01 | 2006-04-06 | Stowers Institute For Medical Research | Methods and compositions for controlling hair follicle stem cell fate |
| US7964571B2 (en) | 2004-12-09 | 2011-06-21 | Egen, Inc. | Combination of immuno gene therapy and chemotherapy for treatment of cancer and hyperproliferative diseases |
| CN101163494A (zh) * | 2005-02-23 | 2008-04-16 | Uab研究基金会 | 烷基糖苷增强的接种 |
| US20080193386A1 (en) * | 2005-03-24 | 2008-08-14 | Medigenes Co., Ltd | Compositions for Treating Alopecia or Promoting Hair Growth |
| WO2006128084A2 (en) * | 2005-05-27 | 2006-11-30 | The Trustees Of Columbia University In The City Of New York | Trps1-mediated modulation of hair growth |
| AU2006291429B2 (en) * | 2005-09-15 | 2013-04-04 | Biontech Delivery Technologies Gmbh | Improvements in or relating to amphoteric liposomes |
| US7718193B2 (en) * | 2006-03-16 | 2010-05-18 | University Of Washington | Temperature- and pH-responsive polymer compositions |
| US20080193514A1 (en) * | 2006-11-02 | 2008-08-14 | Transcu Ltd. | Compostions and methods for iontophoresis delivery of active ingredients through hair follicles |
| DE102006060154A1 (de) * | 2006-12-18 | 2008-06-19 | Henkel Kgaa | Verfahren zur molekularen Charakterisierung von ergrautem und pigmentiertem Haar |
| US7981688B2 (en) | 2007-03-08 | 2011-07-19 | University Of Washington | Stimuli-responsive magnetic nanoparticles and related methods |
| CA2930681C (en) | 2007-04-09 | 2019-10-15 | The Board Of Trustees Of The University Of Arkansas | Fusion protein of collagen-binding domain and parathyroid hormone |
| FR2918885B1 (fr) | 2007-07-17 | 2009-08-28 | Oreal | Utilisation d'extrait de bacterie cultivee sur eau thermale pour diminuer les poches et/ou les cernes perioculaires |
| US9144546B2 (en) | 2007-08-06 | 2015-09-29 | Clsn Laboratories, Inc. | Nucleic acid-lipopolymer compositions |
| FR2920309B1 (fr) | 2007-08-28 | 2010-05-28 | Galderma Res & Dev | Utilisation de travoprost pour traiter la chute des cheveux |
| WO2009068033A2 (en) | 2007-11-26 | 2009-06-04 | Santaris Pharma A/S | Lna antagonists targeting the androgen receptor |
| CA2716872C (en) * | 2008-02-29 | 2015-02-10 | Ferrosan Medical Devices A/S | Device for promotion of hemostasis and/or wound healing |
| FR2928546B1 (fr) * | 2008-03-17 | 2013-08-02 | Oreal | Utilisation d'inhibiteurs de la dopa decarboxylase pour la pigmentation capillaire. |
| FR2928544A1 (fr) * | 2008-03-17 | 2009-09-18 | Oreal | Utilisation d'inhibiteurs de la dopamine-beta hydroxylase pour la pigmentation capillaire. |
| FR2928545B1 (fr) * | 2008-03-17 | 2013-08-02 | Oreal | Utilisation d'inhibiteurs de monoamines oxydases pour la pigmentation capillaire |
| FR2928543B1 (fr) * | 2008-03-17 | 2013-08-02 | Oreal | Utilisation d'inhibiteurs de la xanthine oxydase pour la pigmentation capillaire |
| FR2929118B1 (fr) | 2008-03-28 | 2010-05-07 | Oreal | Utilisation de l'association de madecassoside et/ou de terminoloside et d'une arginine pour induire et/ou stimuler la croissance de ces fibres keratiniques humaines et/ou freiner leur chute |
| FR2929117B1 (fr) | 2008-03-28 | 2010-05-07 | Oreal | Utilisation de l'association du 2,4-diaminopyrimidine 3-n-oxyde et du madecassosside et/ou du terminoloside pour induire et/ou stimuler la croissance de ces fibres keratiniques humaines et/ou freiner leur chute |
| US8426214B2 (en) * | 2009-06-12 | 2013-04-23 | University Of Washington | System and method for magnetically concentrating and detecting biomarkers |
| US20110117668A1 (en) * | 2009-11-09 | 2011-05-19 | University Of Washington Through Its Center For Commercialization | Self-powered smart diagnostic devices |
| US9080933B2 (en) | 2009-11-09 | 2015-07-14 | University Of Washington Through Its Center For Commercialization | Stimuli-responsive polymer diagnostic assay comprising magnetic nanoparticles and capture conjugates |
| AU2011326034B2 (en) | 2010-11-12 | 2016-02-04 | Roche Innovation Center Copenhagen A/S | Compositions and methods for treating androgen receptor dependent disorders including cancers |
| AU2012249474A1 (en) | 2011-04-28 | 2013-11-07 | Stc.Unm | Porous nanoparticle-supported lipid bilayers (protocells) for targeted delivery and methods of using same |
| AU2012284147A1 (en) * | 2011-07-19 | 2014-02-27 | Stc. Unm | Intraperitoneally-administered nanocarriers that release their therapeutic load based on the inflammatory environment of cancers |
| JP2014528276A (ja) | 2011-09-30 | 2014-10-27 | テイコク ファーマ ユーエスエー インコーポレーテッド | 一般用医薬品廃棄システム |
| WO2013049380A1 (en) | 2011-09-30 | 2013-04-04 | Teikoku Pharma Usa, Inc. | Transdermal patch disposal system |
| US9579273B2 (en) | 2011-12-14 | 2017-02-28 | The Kitasato Institute | Delivery of therapeutic agents by a collagen binding protein |
| WO2013120060A1 (en) | 2012-02-09 | 2013-08-15 | The Board Of Trustees Of The University Of Arkansas | Delivery of therapeutic agents by a collagen binding protein |
| US9649388B2 (en) | 2012-01-18 | 2017-05-16 | Bioneer Corporation | Magnetic nanoparticle-samirna complex and method for preparing same |
| CN104159527B (zh) | 2012-03-06 | 2017-04-12 | 弗罗桑医疗设备公司 | 包含止血糊剂的压力容器 |
| RU2636240C2 (ru) | 2012-06-12 | 2017-11-21 | Ферросан Медикал Дивайсиз А/С | Сухая гемостатическая композиция |
| RU2015104158A (ru) * | 2012-07-10 | 2016-08-27 | Конинклейке Филипс Н.В. | Высвобождение молекул из контейнера посредством селективного нагрева волос |
| EP2877573B1 (de) * | 2012-07-26 | 2016-09-21 | Unilever N.V. | Verfahren zur herstellung rekombinanter menschlicher tyrosinase |
| EP3696276A1 (de) | 2013-02-25 | 2020-08-19 | Novartis AG | Neuartige androgenrezeptormutation |
| JP6390873B2 (ja) | 2013-06-21 | 2018-09-19 | フェッローサン メディカル ディバイス エー／エス | 減圧膨張させた乾燥組成物およびそれを保持するためのシリンジ |
| CN105705639A (zh) | 2013-07-05 | 2016-06-22 | 柏业公司 | 登革病毒相关的基因特异性siRNA、包含该siRNA的双链寡RNA分子、和包含它们的用于抑制登革病毒复制的组合物 |
| BR112016000160B1 (pt) | 2013-07-05 | 2021-06-08 | Bioneer Corporation | estrutura de oligonucleotídeo tipo nanopartícula melhorada tendo alta eficiência e método para a preparação da mesma |
| KR20150006742A (ko) * | 2013-07-09 | 2015-01-19 | (주)바이오니아 | 간암 연관 유전자 특이적 siRNA, 그러한 siRNA를 포함하는 이중나선 올리고 RNA 구조체 및 이를 포함하는 암 예방 또는 치료용 조성물 |
| BR112016013322B1 (pt) | 2013-12-11 | 2020-07-21 | Ferrosan Medical Devices A/S | métodos para preparação de uma composição seca e para reconstituir uma composição seca, composição seca, uso de uma composição seca, e, kit |
| EP3128008B1 (de) | 2014-04-04 | 2024-05-29 | Bioneer Corporation | Doppelsträngige-oligo-rna und pharmazeutische zusammensetzung damit zur prävention oder behandlung von fibrose oder atemwegserkrankungen |
| BR112017007466B1 (pt) | 2014-10-13 | 2021-03-02 | Ferrosan Medical Devices A/S | método para preparar uma composição seca, método para reconstituir a composição seca, pasta, composição seca, recipiente, kit homeostático, e, uso de uma composição seca |
| RU2705905C2 (ru) | 2014-12-24 | 2019-11-12 | Ферросан Медикал Дивайсиз А/С | Шприц для удерживания и смешивания первого и второго веществ |
| CA2986981A1 (en) | 2015-07-03 | 2017-01-12 | Ferrosan Medical Devices A/S | Syringe for mixing two components and for retaining a vacuum in a storage condition |
| WO2018148573A1 (en) | 2017-02-10 | 2018-08-16 | The Board Of Trustees Of The University Of Arkansas | Collagen-binding agent compositions and methods of using the same |
| US11389844B2 (en) | 2018-03-20 | 2022-07-19 | Verde Environmental Technologies, Inc. | Blister pack disposal system |
| EP4321182A3 (de) | 2018-05-09 | 2024-05-29 | Ferrosan Medical Devices A/S | Verfahren zur herstellung einer hämostatischen zusammensetzung |
| CN112245571A (zh) * | 2020-09-16 | 2021-01-22 | 陕西中鸿科瑞再生医学研究院有限公司 | 一种用于乌发的脂质体制剂及其制备方法 |
| US12403179B2 (en) | 2021-02-18 | 2025-09-02 | The Board Of Trustees Of The University Of Arkansas | Release of growth factors at wound healing stages |
| US12005134B2 (en) * | 2021-06-30 | 2024-06-11 | Abe Pharmaceutical | Composition for stimulating facial hair growth and methods of manufacturing a composition for stimulating facial hair growth |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5147778B2 (de) | 1973-12-01 | 1976-12-16 | ||
| US4925661A (en) * | 1984-04-19 | 1990-05-15 | Leaf Huang | Target-specific cytotoxic liposomes |
| US4957735A (en) * | 1984-06-12 | 1990-09-18 | The University Of Tennessee Research Corporation | Target-sensitive immunoliposomes- preparation and characterization |
| US4755388A (en) * | 1984-11-09 | 1988-07-05 | The Regents Of The University Of California | Liposome-encapsulated 5-fluoropyrimidines and methods for their use |
| US5223263A (en) * | 1988-07-07 | 1993-06-29 | Vical, Inc. | Liponucleotide-containing liposomes |
| GB8604360D0 (en) * | 1986-02-21 | 1986-03-26 | Univ Dundee | Stimulation of hair growth |
| US4806344A (en) | 1987-01-05 | 1989-02-21 | Gaskin Frances C | Sun protectant composition and method |
| US4828837A (en) * | 1987-03-30 | 1989-05-09 | Liposome Technology, Inc. | Non-crystalline minoxidil composition, its production and application |
| US5030442A (en) | 1987-03-30 | 1991-07-09 | Liposome Technology, Inc. | Non-crystalline minoxidil composition |
| US5290562A (en) * | 1987-11-27 | 1994-03-01 | L V M H Recherche | Compositions and methods employing liposomes including tyrosine or a tyrosine derivative |
| FR2628317B1 (fr) * | 1988-03-09 | 1991-11-08 | Lvmh Rech | Composition a base de phases lamellaires lipidiques hydratees ou de liposomes contenant un extrait de scutellaria, ou au moins un flavonoide tel que baicaleine ou baicaline et composition cosmetique ou pharmaceutique, notamment dermatologique, a activite anti-allergique, anti-inflammatoire ou anti-vieillissement, l'incorporant |
| US5077211A (en) * | 1988-07-06 | 1991-12-31 | Applied Genetics, Inc. | Purification and administration of dna repair enzymes |
| US5190762A (en) * | 1988-07-06 | 1993-03-02 | Applied Genetics, Inc. | Method of administering proteins to living skin cells |
| US5210076A (en) * | 1988-09-13 | 1993-05-11 | Berliner David L | Methods of treating Parkinson's disease using melanin |
| IT1231260B (it) * | 1988-11-16 | 1991-11-28 | Sergio Bertini Curri | Farmaco e metodo per aumentare volume e velocita' del flusso microcircolatorio capillare a livello cutaneo |
| US5618798A (en) | 1989-04-20 | 1997-04-08 | Bar-Shalom; Daniel | Use of sucralfate to treat baldness |
| FR2648132B1 (fr) * | 1989-06-08 | 1991-09-13 | Thorel Jean | Composes pigmentogenes, leurs vehicules de diffusion, compositions les contenant et leur procede de preparation |
| FR2654935B1 (fr) * | 1989-11-28 | 1994-07-01 | Lvmh Rech | Utilisation de xanthines, eventuellement incorporees dans des liposomes, pour favoriser la pigmentation de la peau ou des cheveux. |
| GB9014221D0 (en) * | 1990-06-26 | 1990-08-15 | Janssen Pharmaceutica Nv | Method of treating alopecia |
| US5723149A (en) | 1990-11-21 | 1998-03-03 | Lvmh Recherche | Use of medicago saponins for the preparation of cosmetic or pharmaceutical compositions, especially dermatological compositions, promoting renewal of the epidermis, stimulating hair regrowth or delaying hair loss |
| FR2669225B1 (fr) * | 1990-11-21 | 1993-11-12 | Lvmh Recherche Gie | Utilisation de saponines de medicago pour la preparation de compositions cosmetiques ou pharmaceutiques, notamment dermatologiques. |
| DE4113346A1 (de) * | 1991-04-24 | 1992-10-29 | Lang Erich | Zubereitung zur kraeftigung und regeneration des haarwuchses |
| AU4228093A (en) * | 1992-05-04 | 1993-11-29 | David L. Berliner | Process for absorbing ultraviolet radiation using dispersed melanin |
| US5641509A (en) * | 1992-06-26 | 1997-06-24 | Lancaster Group Ag | Preparation for topical use |
| FR2694768B1 (fr) * | 1992-07-30 | 1994-12-23 | Pasteur Institut | Séquences d'oligonucléotides pour la détection spécifique de mollicutes par amplication de gènes conservés. |
| US5302389A (en) * | 1992-08-17 | 1994-04-12 | Board Of Regents, The University Of Texas System | Method for treating UV-induced suppression of contact hypersensitivity by administration of T4 endonuclease |
| DE69429337T3 (de) | 1993-04-02 | 2012-08-30 | Anticancer Inc. | Verfahren zur verabreichung von förderlichen zusammensetzungen auf die haarfollikel |
-
1994
- 1994-04-01 DE DE69429337T patent/DE69429337T3/de not_active Expired - Lifetime
- 1994-04-01 EP EP94913349A patent/EP0692972B2/de not_active Expired - Lifetime
- 1994-04-01 WO PCT/US1994/003634 patent/WO1994022468A1/en not_active Ceased
- 1994-04-01 JP JP6522428A patent/JP2950520B2/ja not_active Expired - Lifetime
- 1994-04-01 CA CA002159626A patent/CA2159626C/en not_active Expired - Fee Related
- 1994-04-01 AT AT94913349T patent/ATE209887T1/de not_active IP Right Cessation
- 1994-04-01 AU AU65545/94A patent/AU6554594A/en not_active Abandoned
-
1995
- 1995-06-07 US US08/486,520 patent/US5753263A/en not_active Expired - Lifetime
-
1997
- 1997-05-20 US US08/858,469 patent/US5914126A/en not_active Expired - Lifetime
- 1997-05-20 US US08/858,970 patent/US5965157A/en not_active Expired - Lifetime
- 1997-05-20 US US08/858,929 patent/US6224901B1/en not_active Expired - Lifetime
-
1999
- 1999-05-21 US US09/316,763 patent/US6261596B1/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| AU6554594A (en) | 1994-10-24 |
| EP0692972B1 (de) | 2001-12-05 |
| US6224901B1 (en) | 2001-05-01 |
| US6261596B1 (en) | 2001-07-17 |
| CA2159626C (en) | 2001-10-02 |
| JPH08511510A (ja) | 1996-12-03 |
| EP0692972A4 (de) | 1998-05-06 |
| WO1994022468A1 (en) | 1994-10-13 |
| DE69429337T3 (de) | 2012-08-30 |
| JP2950520B2 (ja) | 1999-09-20 |
| US5965157A (en) | 1999-10-12 |
| US5914126A (en) | 1999-06-22 |
| DE69429337D1 (de) | 2002-01-17 |
| DE69429337T2 (de) | 2002-10-10 |
| EP0692972A1 (de) | 1996-01-24 |
| CA2159626A1 (en) | 1994-10-13 |
| EP0692972B2 (de) | 2012-03-21 |
| US5753263A (en) | 1998-05-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE209887T1 (de) | Verfahren zur verabreichung von förderlichen zusammensetzungen auf die haarfollikel | |
| EP0796081B1 (de) | Elektrophoretischer apparat und verfahren zur anwendung von therapeutischen-, kosmetischen- und farblösungen im haar | |
| DE69837274D1 (de) | Verfahren zur verkapselung von nukleinsäuren in lipiddoppelschichten | |
| US5532001A (en) | Stimulation of tanning by DNA fragments or single-stranded DNA | |
| US8946402B2 (en) | Inhibition of hairless protein mRNA | |
| US4935231A (en) | Use of thioredoxin, thioredoxin-derived, or thioredoxin-like dithiol peptides in hair care preparations | |
| ATE334146T1 (de) | Verfahren zur herstellung von erythropoietin frei von tierischen proteinen | |
| NO921875L (no) | Metallpeptidpreparater og fremgangsmaater for aa stimulere haarvekst | |
| BR0108959A (pt) | Composições de poloxmero ou poloxamina melhoradas para distribuição de ácido nucléico | |
| CA2042014A1 (en) | Method of treating or preventing baldness with compositions containing fibroblast growth factor | |
| FR2781157B1 (fr) | Composition anti-inflammatoire | |
| US20060270621A1 (en) | Inhibition of hair growth with RNAi targeting desmoglein 4 and nude mRNAs | |
| MXPA00006306A (es) | Compuestos del canal de ion del cerebro o corazon, regulados por nucleotidos ciclicos y usos de los mismos. | |
| GB2321852A (en) | Effect of Fibroblast Growth Factor 10 (FGF-10) on Hair Cells. | |
| IT1228210B (it) | Procedimento per la introduzione di dna esogeno nelle cellule somatiche e germinali di animali. | |
| ATE336992T1 (de) | Verwendung von alkansäuren-enthaltenden zusammensetzungen zur behandlung von nagelpilz- erkrankungen | |
| DE59510829D1 (de) | Gentherapeutisches verfahren unter verwendung von dna-vektoren ohne selektionsmarker-gen | |
| DE69529750D1 (de) | Verbesserungen in der herstellung von proteinen in wirtszellen | |
| BR9002240A (pt) | Processo para a preparacao de uma composicao conservada apropriada para aplicacao topica a pele e composicao | |
| Karlson | Regulation of gene activity by hormones | |
| WO1995035373A3 (en) | Nucleic acid molecules encoding human contactin | |
| DE19514647B4 (de) | Verwendung von Chromogranin A zum Fördern des Haarwuchses | |
| FI20000956A0 (fi) | Kosmeettinen tai ihonhoidollinen voidekoostumus, sen valmistusmenetelmä ja käyttö | |
| WO2002010375A1 (fr) | Sequence genique de tete d'origine humaine, vecteur genetique et procede d'expression dudit gene | |
| ATE298000T1 (de) | Eine methode zur erhöhung der transfektion von zellen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |